Lexicon Pharmaceuticals (LXRX) Asset Utilization Ratio (2011 - 2026)
Lexicon Pharmaceuticals' (LXRX) quarterly Asset Utilization Ratio came in at 0.31 in Q1 2026, up 193.08% year-on-year from 0.1 in Q1 2025, and up 20.46% on a QoQ basis from 0.25 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 16 years of Asset Utilization Ratio data on file, last reported at 0.31 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 193.08% year-over-year to 0.31 in Q1 2026; TTM through Mar 2026 was 0.31, a 193.08% increase from a year earlier, with the FY2025 full-year figure at 0.21, up 74.97% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.31, up from 0.25 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for LXRX reached as high as 0.33 in Q3 2025 and fell as low as 0.0 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 0.08 across 5 years, with a median of 0.01 in 2024.
- Across the five-year window, Asset Utilization Ratio plunged 80.1% in 2022 and surged 3547.02% in 2024, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.0 in 2022, then jumped by 2557.26% to 0.0 in 2023, then soared by 1979.57% to 0.1 in 2024, then surged by 154.25% to 0.25 in 2025, then advanced by 20.46% to 0.31 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.31 in Q1 2026, 0.25 in Q4 2025, and 0.33 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | 0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | 0.25 |
| Sep 30, 2025 | 0.33 |
| Jun 30, 2025 | 0.22 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | 0.10 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.04 |